{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:06:47Z","timestamp":1793383607787,"version":"4.5.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,8]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Anaesthesia and sedation are ubiquitous in contemporary medical practice. Developments in anaesthetic pharmacology are targeted on reducing physiological disturbance whilst maintaining or improving titrateability, recovery profile and patient experience. Remimazolam is a new short-acting benzodiazepine in the final stages of clinical development.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Clinical experience with remimazolam comprises volunteer studies and a limited number of clinical investigations. In addition, laboratory investigations explore the implications of its \u2018soft drug\u2019 pharmacology.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Remimazolam provides effective procedural sedation with superior success rates and recovery profile when compared to midazolam. Comparisons with propofol are required. Preliminary studies suggest potential for using remimazolam as the hypnotic component of general anaesthesia. Definitive studies are awaited. As a benzodiazepine, remimazolam could be evaluated as an anticonvulsant and for intensive care sedation.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/aco.0000000000000877","type":"journal-article","created":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T12:30:55Z","timestamp":1591878655000},"page":"506-511","source":"Crossref","is-referenced-by-count":178,"title":["Remimazolam for anaesthesia or sedation"],"prefix":"10.1097","volume":"33","author":[{"given":"J. Robert","family":"Sneyd","sequence":"first","affiliation":[{"name":"Faculty of Health: Medicine, Dentistry and Human Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann E.","family":"Rigby-Jones","sequence":"additional","affiliation":[{"name":"Lecturer in Pharmacology (Education), Faculty of Health: Medicine, Dentistry and Human Sciences, University of Plymouth, Plymouth, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,6,8]]},"reference":[{"key":"R1-20230827","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/ALN.0b013e3181ae8460","article-title":"Is anesthesiology going soft? Trends in fragile pharmacology","volume":"111","author":"Egan","year":"2009","journal-title":"Anesthesiology"},{"key":"R2-20230827","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jpba.2017.01.016","article-title":"Metabolite characterization of a novel sedative drug, remimazolam in human plasma and urine using ultra high-performance liquid chromatography coupled with synapt high-definition mass spectrometry","volume":"137","author":"Zhou","year":"2017","journal-title":"J Pharm Biomed Anal"},{"key":"R3-20230827","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.2147\/DDDT.S186759","article-title":"Metabolism of remimazolam in primary human hepatocytes during continuous long-term infusion in a 3-D bioreactor system","volume":"13","author":"Freyer","year":"2019","journal-title":"Drug Des Devel Ther"},{"issue":"(Suppl 3)","key":"R4-20230827","first-page":"3","article-title":"Intravenous anaesthesia and the need for new agents","volume":"61","author":"Dundee","year":"1985","journal-title":"Postgrad Med J"},{"key":"R5-20230827","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1097\/ALN.0000000000003102","article-title":"Pharmacokinetics and pharmacodynamics of remimazolam (CNS 7056) after continuous infusion in healthy male volunteers. Part II. Pharmacodynamics of electroencephalogram effects","volume":"132","author":"Eisenried","year":"2020","journal-title":"Anesthesiology"},{"key":"R6-20230827","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/ALN.0000000000003103","article-title":"Pharmacokinetics and Pharmacodynamics of Remimazolam (CNS 7056) after Continuous Infusion in Healthy Male Volunteers: Part I. Pharmacokinetics and Clinical Pharmacodynamics","volume":"132","author":"Sch\u00fcttler","year":"2020","journal-title":"Anesthesiology"},{"key":"R7-20230827","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1213\/ANE.0b013e31823f0c28","article-title":"A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part I. Safety, efficacy, and basic pharmacokinetics","volume":"115","author":"Antonik","year":"2012","journal-title":"Anesth Analg"},{"key":"R8-20230827","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1213\/ANE.0b013e318241f68a","article-title":"A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part II. Population pharmacokinetic and pharmacodynamic modeling and simulation","volume":"115","author":"Wiltshire","year":"2012","journal-title":"Anesth Analg"},{"key":"R9-20230827","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/anae.12940","article-title":"Sedation practice in six acute hospitals - a snapshot survey","volume":"70","author":"South West Anaesthetic Research","year":"2015","journal-title":"Anaesthesia"},{"key":"R11-20230827","first-page":"E107","article-title":"High efficacy with deep nurse-administered propofol sedation for advanced gastroenterologic endoscopic procedures","volume":"4","author":"Jensen","year":"2016","journal-title":"Endosc Int Open"},{"key":"R12-20230827","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/EJA.0b013e328348a977","article-title":"Nonanaesthesiologists should not be allowed to administer propofol for procedural sedation: a Consensus Statement of 21 European National Societies of Anaesthesia","volume":"28","author":"Perel","year":"2011","journal-title":"Eur J Anaesthesiol"},{"key":"R13-20230827","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/bja\/aew393","article-title":"Safety of sedation for gastrointestinal endoscopy in a group of university-affiliated hospitals: a prospective cohort study","volume":"118","author":"Leslie","year":"2017","journal-title":"Br J Anaesth"},{"key":"R14-20230827","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1016\/j.cgh.2018.12.037","article-title":"Substantial increase in anesthesia assistance for outpatient colonoscopy and associated cost nationwide","volume":"17","author":"Krigel","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R15-20230827","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2147\/CEG.S186393","article-title":"Propofol sedation in colonoscopy: from satisfied patients to improved quality indicators","volume":"12","author":"Abu Baker","year":"2019","journal-title":"Clin Exp Gastroenterol"},{"key":"R16-20230827","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.gie.2015.08.062","article-title":"A phase IIb study comparing the safety and efficacy of remimazolam and midazolam in patients undergoing colonoscopy","volume":"83","author":"Pambianco","year":"2016","journal-title":"Gastrointest Endosc"},{"key":"R17-20230827","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.gie.2018.04.2351","article-title":"A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy","volume":"88","author":"Rex","year":"2018","journal-title":"Gastrointest Endosc"},{"issue":"(Suppl 1)","key":"R18-20230827","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1136\/thoraxjnl-2013-203618","article-title":"British Thoracic Society guideline for diagnostic flexible bronchoscopy in adults: accredited by NICE","volume":"68","author":"Du Rand","year":"2013","journal-title":"Thorax"},{"key":"R19-20230827","doi-asserted-by":"crossref","first-page":"e12229","DOI":"10.1097\/MD.0000000000012229","article-title":"The comparison of propofol and midazolam for bronchoscopy: a meta-analysis of randomized controlled studies","volume":"97","author":"Wang","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"R20-20230827","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.chest.2018.09.015","article-title":"Safety and efficacy of remimazolam compared with placebo and midazolam for moderate sedation during bronchoscopy","volume":"155","author":"Pastis","year":"2019","journal-title":"Chest"},{"key":"R26-20230827","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1213\/ANE.0b013e3182a705ae","article-title":"A phase Ib, dose-finding study of multiple doses of remimazolam (CNS 7056) in volunteers undergoing colonoscopy","volume":"117","author":"Worthington","year":"2013","journal-title":"Anesth Analg"},{"key":"R27-20230827","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1399-6576.1990.tb03161.x","article-title":"Recovery from total intravenous anaesthesia. Propofol versus midazolam-flumazenil","volume":"34","author":"Steib","year":"1990","journal-title":"Acta Anaesthesiol Scand"},{"key":"R28-20230827","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1213\/01.ANE.0000074534.52751.C5","article-title":"Remifentanil manual versus target-controlled infusion","volume":"97","author":"Sneyd","year":"2003","journal-title":"Anesth Analg"},{"key":"R29-20230827","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1097\/00000542-199704000-00014","article-title":"Bispectral analysis measures sedation and memory effects of propofol, midazolam, isoflurane, and alfentanil in healthy volunteers","volume":"86","author":"Glass","year":"1997","journal-title":"Anesthesiology"},{"key":"R30-20230827","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/0009-9236(95)90023-3","article-title":"Topographic electroencephalogram of propofol-induced conscious sedation","volume":"58","author":"Kishimoto","year":"1995","journal-title":"Clin Pharmacol Ther"},{"key":"R31-20230827","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2044.2010.06332.x","article-title":"The anaesthetist and the environment","volume":"65","author":"Sneyd","year":"2010","journal-title":"Anaesthesia"},{"key":"R32-20230827","doi-asserted-by":"crossref","first-page":"e525","DOI":"10.1016\/j.bja.2019.07.023","article-title":"Can anaesthetic-analgesic technique during cancer surgery of curative intent influence recurrence or metastasis? An update","volume":"123","author":"Buggy","year":"2019","journal-title":"Br J Anaesth"},{"key":"R33-20230827","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/bja\/aex238","article-title":"Thinking, fast and slow: highlights from the 2016 BJA seminar on anaesthetic neurotoxicity and neuroplasticity","volume":"119","author":"Soriano","year":"2017","journal-title":"Br J Anaesth"},{"key":"R34-20230827","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.bja.2018.04.036","article-title":"Intraoperative hypotension and the risk of postoperative adverse outcomes: a systematic review","volume":"121","author":"Wesselink","year":"2018","journal-title":"Br J Anaesth"},{"key":"R35-20230827","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.bja.2018.07.003","article-title":"Making sense of the impact of intraoperative hypotension: from populations to the individual patient","volume":"121","author":"Ke","year":"2018","journal-title":"Br J Anaesth"},{"key":"R36-20230827","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1213\/ANE.0000000000000559","article-title":"Alphaxalone reformulated: a water-soluble intravenous anesthetic preparation in sulfobutyl-ether-beta-cyclodextrin","volume":"120","author":"Goodchild","year":"2015","journal-title":"Anesth Analg"},{"key":"R37-20230827","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/BF03039453","article-title":"Midazolam compared with thiopentone as a hypnotic component in balanced anaesthesia: a randomized, double-blind study","volume":"26","author":"Reves","year":"1979","journal-title":"Can Anaesth Soc J"},{"key":"R38-20230827","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/00000542-197807000-00012","article-title":"A water-soluble benzodiazepine, RO21-3981, for induction of anesthesia","volume":"49","author":"Fragen","year":"1978","journal-title":"Anesthesiology"}],"container-title":["Current Opinion in Anaesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ACO.0000000000000877","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T03:48:08Z","timestamp":1693108088000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/ACO.0000000000000877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,8]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/aco.0000000000000877","relation":{},"ISSN":["0952-7907","1473-6500"],"issn-type":[{"value":"0952-7907","type":"print"},{"value":"1473-6500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,8]]}}}